VDR and Hepatic fibrosis: Evidence from a study of hepatic fibrosis demonstrates that the anti-fibrotic effects of vitamin D receptor ligands are generated by binding of the vitamin D receptor, which then displaces the TGFβ-directed Smad3 occupation of profibrotic target genes and inhibits chromatin remodeling [533].